THE DISPOSITION OF MORPHINE AND ITS METABOLITES IN THE IN-SITU RAT ISOLATED-PERFUSED LIVER

被引:34
作者
EVANS, AM
SHANAHAN, K
机构
[1] School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, 5000, North Terrace
关键词
D O I
10.1111/j.2042-7158.1995.tb05805.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A specific HPLC method with UV detection was used to investigate the disposition of morphine and its metabolites in the in-situ rat isolated perfused liver preparation. Livers of male Sprague-Dawley rats (n = 4) were perfused under single pass conditions with protein- and erythrocyte-free perfusate, containing 2.66 mu M morphine, for up to 90 min. The concentration of morphine, normorphine and morphine-3-glucuronide (M3G) in outflow perfusate, and the biliary excretion of M3G and normorphine glucuronide, all reached steady-state levels within 15-20 min after commencing perfusion. At steady-state, the mean (+/- s.d.) extraction ratio of morphine was 0.87 +/- 0.06 and clearance (26.0 +/- 1.7 mL min(-1)) approached perfusate flow rate (30 mL min(-1)). Although M3G was the main metabolite, accounting for 72.8 +/- 12.7% of eliminated morphine, a significant proportion (21.6 +/- 13.5%) was N-demethylated to normorphine and was recovered as unchanged normorphine in outflow perfusate and normorphine glucuronide in bile. The biliary extraction ratio of hepatically-formed M3G was 0.61 +/- 0.31. Results from an additional six experiments, in which livers were perfused with 1.33 and 2.66 mu M of morphine for 30 min each in a balanced cross-over manner, indicated that the disposition of morphine and its metabolites was approximately linear within this concentration range.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 45 条
[1]   MORPHINE-6-GLUCURONIDE - ANALGESIC EFFECTS AND RECEPTOR-BINDING PROFILE IN RATS [J].
ABBOTT, FV ;
PALMOUR, RM .
LIFE SCIENCES, 1988, 43 (21) :1685-1695
[2]  
AUANSAKUL AC, 1982, DRUG METAB DISPOS, V10, P344
[3]   SEX-DIFFERENCES AND ENDOCRINE REGULATION OF MORPHINE OXIDATION IN RAT-LIVER [J].
BLANCK, A ;
HANSSON, T ;
NASLUND, B ;
RANE, A .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (11) :1820-1822
[4]   MORPHINE-6-GLUCURONIDE MIGHT MEDIATE THE PROLONGED OPIOID EFFECT OF MORPHINE IN ACUTE-RENAL-FAILURE [J].
BODD, E ;
JACOBSEN, D ;
LUND, E ;
RIPEL, A ;
MORLAND, J ;
WIIKLARSEN, E .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1990, 9 (05) :317-321
[5]   METABOLISM OF MORPHINE AND HEROIN IN MAN [J].
BOERNER, U ;
ABBOTT, S ;
ROE, RL .
DRUG METABOLISM REVIEWS, 1975, 4 (01) :39-73
[6]  
BROCK WJ, 1982, DRUG METAB DISPOS, V10, P336
[7]   HEPATIC ENZYME-ACTIVITY IS THE MAJOR FACTOR DETERMINING ELIMINATION RATE OF HIGH-CLEARANCE DRUGS IN CIRRHOSIS [J].
CALLAGHAN, R ;
DESMOND, PV ;
PAULL, P ;
MASHFORD, ML .
HEPATOLOGY, 1993, 18 (01) :54-60
[8]   MORPHINE-6-GLUCURONIDE HAS HIGH-AFFINITY FOR THE OPIOID RECEPTOR [J].
CHRISTENSEN, CB ;
JORGENSEN, LN .
PHARMACOLOGY & TOXICOLOGY, 1987, 60 (01) :75-76
[9]   THE ENANTIOSELECTIVE GLUCURONIDATION OF MORPHINE IN RATS AND HUMANS - EVIDENCE FOR THE INVOLVEMENT OF MORE THAN ONE UDP-GLUCURONOSYLTRANSFERASE ISOENZYME [J].
COUGHTRIE, MWH ;
ASK, B ;
RANE, A ;
BURCHELL, B ;
HUME, R .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (19) :3273-3280
[10]   PHARMACOKINETIC INTERPRETATION OF THE ENTEROHEPATIC RECIRCULATION AND 1ST-PASS ELIMINATION OF MORPHINE IN THE RAT [J].
DAHLSTROM, BE ;
PAALZOW, LK .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (06) :505-519